Dr Nestor Demosthenous discusses the pharmacodynamics of botulinum toxin and the differences between the available preparations. In the 1980s, ophthalmologist Dr Jean Carruthers and dermatologist Dr Alastair Carruthers discovered that one of their patients treated with botulinum neurotoxin (BoNT) for …
Subscriber content
Continue reading this clinical article
To read this post in full you need an Aesthetics Journal subscription. Choose the plan that fits your practice — every paid plan includes the complete peer-reviewed clinical library and CPD-accredited learning.
Already a subscriber? Log in
